Plasma levels of soluble tumor necrosis factor-α receptors are related to total and LDL-cholesterol in lean, but not in obese subjects

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Straczkowski, Marek ^a   Kowalska, Irina ^a   Nikolajuk, Agnieszka ^a   Adamska, Agnieszka ^a   Karolczuk Zarachowicz, Malgorzata ^a   Karczewska Kupczewska, Monika ^a   Kozlowska, Agnieszka ^a   Gorska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL; CHOLESTEROL, LDL; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; PARACRINE COMMUNICATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; THINNESS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746609427     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-14     Document Type: Article

References (30)

1. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
2. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415.
3. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle. Relationship to insulin resistance. J Clin Invest 1996, 97:1111-1116.
4. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997, 46:451-455.
5. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992, 175:323-329.
6. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C: Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998, 47:1757-1762.
7. Hube F, Birgel M, Lee YM, Hauner H: Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulln-dependent diabetes mellitus. Eur J Clin Invest 1999, 29:672-678.
8. Hauner H, Bender M, Haastert B, Hube F: Plasma concentrations of soluble TNFα receptors in obese subjects. Int J Obesity 1998, 22:1239-1243.
9. Memon RA, Grunfeld C, Moser AH, Feingold KR: Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993, 132:2246-2253.
10. Lawler JF Jr, Yin M, Diehl AM, Roberts E, Chatterjee S. Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem 1998, 273:5053-5059.
11. Glenn CL, Wang WY, Benjafield AV, Morris BJ: Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 2000, 9:1943-1949.
12. Benjafield AV, Wang XL, Morris BJ: Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med 2001, 19:109-115.
13. Fernandez-Real JM, Gutierrez C, Ricart W, Castineira MJ, Vendrell J, Richart C: Plasma levels of the soluble fraction of TNFα receptors 1 and 2 are independent determinants of total and LDL-cholesterol concentrations in healthy subjects. Atherosclerosis 1999, 146:321-327.
14. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB: Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001, 157:495-503.
15. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
16. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Plotrowska M, Brzezinska Z, Gorski J: Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004, 53:1215-1221.
17. Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M: Plasma interleukin 10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 2005, 28:2036-2037.
18. Duncombe WS: The colorimetric microdetermination of non-esterified fatty acids in plasma. Clin Chim Acta 1964, 9:122-135.
19. Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I: Soluble tumor necrosis factor-α receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care 2003, 26:875-880.
20. Straczkowski M, Kowalska I, Dzienis-Straczkowska S, Stepien A, Skibinska E, Szelachowska M, Kinalska I: Changes in tumor necrosis factor-α system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol 2001, 145:273-280.
21. Lopes-Virella M, Virella G: Cytokines, modified lipoproteins and arteriosclerosis in diabetes. Diabetes 1996, 45(Suppl 3):40-44.
22. Brito BE, Romano EL, Grunfeld C: Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolemic rabbits. Clin Exp Immunol 1995, 101:357-361.
23. Henninger DD, Gerritsen ME, Granger DN: LDL receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ Res 1997, 81:274-281.
24. Geurts JMW, Janssen R, van Greevenbroek M, van der Kallen C, Cantor R, Bu X, et al.: Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum Mol Genet 2000, 9:2067-2074.
25. Fernandez-Real JM, Molina A, Broch M, Ricart W, Gutierrez C, Casamitiana R, et al.: Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Diabetes 1999, 48:1108-1112.
26. Straczkowski M, Kowalska I, Stepien A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I: Increased plasma soluble tumor necrosis factor-α receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Care 2002, 25:1824-1828.
27. Kowalska I, Straczkowski M, Nikolajuk A, Krukowska, Kinalska I, Gorska M: Plasma adiponectin concentration and TNFα system activity in lean nondiabetic offspring of type 2 diabetic subjects. Eur J Endocrinol 2006, 154:319-324.
28. Straczkowski M, Lewczuk P, Dzienis-Straczkowska S, Kowalska I, Stepien A, Kinalska I: Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-α system activity. Metabolism 2002, 51:75-78.
29. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I: Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J Clin Endocrinol Metab 2002 87(10):4602-4606.
30. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, et al.: Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002, 33:31-37.